MTOR and acute lymphoblastic leukemia: In T-ALL cell lines simultaneously targeting of Notch1 and PI3k/AKT/ mTOR signaling pathways can increase the cytotoxicity of the drugs .The combination of AZD5363 and Compound E as a possible treatment of T-ALL provides a basis for future investigations.